VERACYTE, INC. Cost, Amortization
VERACYTE, INC. (VCYT) reported Cost, Amortization of $2.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSoldAmortization · last filed 2026-07-31
- VERACYTE, INC. cost, amortization for the quarter ending 2026-06-30 was $2.74M, a 2.77% increase year-over-year.
- VERACYTE, INC. cost, amortization for the quarter ending 2026-03-31 was $2.71M, a 4.72% increase year-over-year.
- VERACYTE, INC. cost, amortization for the quarter ending 2025-12-31 was $2.71M, a 3.70% decline year-over-year.
- VERACYTE, INC. cost, amortization for the quarter ending 2025-09-30 was $2.71M, a 7.20% decline year-over-year.
- VERACYTE, INC. cost, amortization for fiscal 2025 was $10.67M, a 7.67% decline from fiscal 2024.
- VERACYTE, INC. cost, amortization for fiscal 2024 was $11.55M, a 37.44% decline from fiscal 2023.
- VERACYTE, INC. cost, amortization for fiscal 2023 was $18.46M, a 4.20% decline from fiscal 2022.
- VERACYTE, INC. cost, amortization for fiscal 2022 was $19.27M.
| Period end | Cost, Amortization 3 month | Cost, Amortization 6 month | Cost, Amortization 9 month | Cost, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.74M 10-Q · filed 2026-07-31 | $5.45M 10-Q · filed 2026-07-31 | $8.15M derived: sum of 3 quarters · filed 2026-07-31 | $10.86M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $2.71M 10-Q · filed 2026-05-06 | $5.41M derived: sum of 2 quarters · filed 2026-05-06 | $8.12M derived: sum of 3 quarters · filed 2026-05-06 | $10.79M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.41M derived: sum of 2 quarters · filed 2026-02-26 | $8.08M derived: sum of 3 quarters · filed 2026-07-31 | $10.67M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.71M 10-Q · filed 2025-11-05 | $5.37M derived: sum of 2 quarters · filed 2026-07-31 | $7.96M 10-Q · filed 2025-11-05 | $10.77M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $2.67M 10-Q · filed 2026-07-31 | $5.25M 10-Q · filed 2026-07-31 | $8.06M derived: sum of 3 quarters · filed 2026-07-31 | $10.98M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $2.58M 10-Q · filed 2026-05-06 | $5.40M derived: sum of 2 quarters · filed 2026-05-06 | $8.31M derived: sum of 3 quarters · filed 2026-05-06 | $11.22M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.73M derived: sum of 2 quarters · filed 2026-02-26 | $8.64M derived: sum of 3 quarters · filed 2026-02-26 | $11.55M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.92M 10-Q · filed 2025-11-05 | $5.83M derived: sum of 2 quarters · filed 2025-11-05 | $8.74M 10-Q · filed 2025-11-05 | $12.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.91M 10-Q · filed 2025-08-07 | $5.82M 10-Q · filed 2025-08-07 | $9.86M derived: sum of 3 quarters · filed 2026-02-26 | $14.67M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.92M 10-Q · filed 2025-05-08 | $6.95M derived: sum of 2 quarters · filed 2026-02-26 | $11.76M derived: sum of 3 quarters · filed 2026-02-26 | $16.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.85M derived: sum of 2 quarters · filed 2026-02-26 | $13.66M derived: sum of 3 quarters · filed 2026-02-26 | $18.46M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.81M 10-Q · filed 2024-11-07 | $9.63M derived: sum of 2 quarters · filed 2024-11-07 | $14.43M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $4.81M 10-Q · filed 2024-08-07 | $9.62M 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | $19.27M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |